中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Synthesis of Chiral Piperazines via Hydrogenation of Pyrazines Activated by Alkyl Halides

文献类型:期刊论文

作者Wang, Baomin2; Huang, Wen-Xue1,2; Liu, Lian-Jin1; Wu, Bo1; Feng, Guang-Shou1; Zhou, Yong-Gui1
刊名ORGANIC LETTERS
出版日期2016-07-01
卷号18期号:13页码:3082-3085
ISSN号1523-7060
DOI10.1021/acs.orglett.6b01190
文献子类Article
英文摘要A facile method has been developed for the synthesis of chiral piperazines through Ir-catalyzed hydrogenation of pyrazines activated by alkyl halides, giving a wide range of chiral piperazines including 3-substituted as well as 2,3- and 3,5-disubstituted ones with up to 96% ee. The high enantioselectivity, easy scalability, and concise drug synthesis demonstrate the practical utility.
WOS关键词CATALYZED ASYMMETRIC HYDROGENATION ; NK1 RECEPTOR ANTAGONIST ; HIV PROTEASE INHIBITOR ; ENANTIOSELECTIVE REDUCTION ; HETEROAROMATIC-COMPOUNDS ; ISOQUINOLINIUM SALTS ; PYRIDINIUM SALTS ; QUINOLINES ; QUINOXALINES ; DERIVATIVES
WOS研究方向Chemistry
语种英语
WOS记录号WOS:000379455300011
出版者AMER CHEMICAL SOC
源URL[http://cas-ir.dicp.ac.cn/handle/321008/170364]  
专题大连化学物理研究所_中国科学院大连化学物理研究所
通讯作者Zhou, Yong-Gui
作者单位1.Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Catalysis, 457 Zhongshan Rd, Dalian 116023, Peoples R China
2.Dalian Univ Technol, Sch Pharmaceut Sci & Technol, State Key Lab Fine Chem, 2 Linggong Rd, Dalian 116024, Peoples R China
推荐引用方式
GB/T 7714
Wang, Baomin,Huang, Wen-Xue,Liu, Lian-Jin,et al. Synthesis of Chiral Piperazines via Hydrogenation of Pyrazines Activated by Alkyl Halides[J]. ORGANIC LETTERS,2016,18(13):3082-3085.
APA Wang, Baomin,Huang, Wen-Xue,Liu, Lian-Jin,Wu, Bo,Feng, Guang-Shou,&Zhou, Yong-Gui.(2016).Synthesis of Chiral Piperazines via Hydrogenation of Pyrazines Activated by Alkyl Halides.ORGANIC LETTERS,18(13),3082-3085.
MLA Wang, Baomin,et al."Synthesis of Chiral Piperazines via Hydrogenation of Pyrazines Activated by Alkyl Halides".ORGANIC LETTERS 18.13(2016):3082-3085.

入库方式: OAI收割

来源:大连化学物理研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。